Randox Provides Improved Stroke and Heart Attack Patient Profiling 11 Aug 2010: Randox now offers Metabolic Syndrome Arrays for the simultaneous determination of analytes associated with Metabolic Syndrome and related disorders for improved patient profiling. Individuals with Metabolic Syndrome are more likely to have a stroke, heart attack or develop type 2 diabetes. Randox Laboratories Ltd
Recent articles:
New Quality Controls from Randox Enable Reliable Patient Results 09 Jul 2010: Randox Laboratories announces expansion to the Acusera with the introduction of several new quality controls. The new range of Liquid controls eliminates the need for reconstitution minimising the risk of human error saving laboratories both time and money. The new lyophilised range of controls ensures a longer shelf life and stability resulting in more convenient storage at 2-8oC and easier transportation. Randox Laboratories Ltd
Randox Annouces New Lithium Kit to Avoid Toxicity and Optimise Treatment 14 May 2010: The new and improved Lithium kit from Randox is intended for the quantitative in vitro determination of Lithium in serum and is suitable for use on a wide range of clinical analysers. Lithium administered as Lithium carbonate has a narrow therapeutic and toxic range and it is important to monitor lithium levels in the serum to avoid toxicity, optimise therapeutic effect and ensure compliance. Randox Laboratories Ltd
New Liquid Quality Control Sera Available Now 11 Feb 2010: The Randox Acusera range of quality control sera is set to expand with the introduction of our new liquid ready to use QC. Liquid controls eliminate the need for reconstitution minimising the risk of human error saving labs both time and money in the process. Randox Laboratories Ltd
Revolutionary Randox Technology Offers Multiple Cardiac Tests within Minutes 08 Oct 2009: Randox Laboratories have launched a revolutionary new Biochip Analyser that will save cardiac patients lives by providing immediate diagnosis at the point of care. The Randox Evidence MultiStat is a revolutionary new desktop analyser which offers up to 8 cardiac results within just 20 minutes. Randox Laboratories Ltd
Randox Announce Three Biochip Arrays for the Detection of a Variety of Antimicrobial Agents 28 Sep 2009: Randox have developed three biochip arrays for the detection of a variety of antimicrobial agents. These arrays enable simultaneous multi-analyte testing of up to 12 antimicrobials from a single sample. Antimicrobial Array I tests for sulphonamides, Array II for general antibiotics and Array III for nitrofurans, chloramphenicol and malachite green. Randox Laboratories Ltd
Swine flu profiling with Randox Cytokine Array 08 May 2009: Most flu infections are harmless, but sometimes a novel strain appears which causes fatalities. Randox has a cytokine biochip array that can help determine the virulence of these novel strains, providing a rapid determination of patients in immediate need of therapy. Randox Laboratories Ltd
Postmortem Toxicology Made Easy 24 Apr 2009: The analysis of postmortem blood is one of the most challenging tasks in forensic toxicology, but Randox can help through the development of their innovative biochip array technology applied to multi-analyte screening. The Randox Drugs of Abuse (DoA) biochips permit the simultaneous analysis of up to 10 drug classes per array from a single blood sample. Randox Laboratories Ltd
blood transfusion
11 Aug 2010: Randox now offers Metabolic Syndrome Arrays for the simultaneous determination of analytes associated with Metabolic Syndrome and related disorders for improved patient profiling. Individuals with Metabolic Syndrome are more likely to have a stroke, heart attack or develop type 2 diabetes.
09 Jul 2010: Randox Laboratories announces expansion to the Acusera with the introduction of several new quality controls. The new range of Liquid controls eliminates the need for reconstitution minimising the risk of human error saving laboratories both time and money. The new lyophilised range of controls ensures a longer shelf life and stability resulting in more convenient storage at 2-8oC and easier transportation.
14 May 2010: The new and improved Lithium kit from Randox is intended for the quantitative in vitro determination of Lithium in serum and is suitable for use on a wide range of clinical analysers. Lithium administered as Lithium carbonate has a narrow therapeutic and toxic range and it is important to monitor lithium levels in the serum to avoid toxicity, optimise therapeutic effect and ensure compliance.
10 Nov 2009: A new revolutionary Biochip Analyser that will save cardiac patients lives by providing immediate diagnosis at the point of care is to be launched by Randox at Medica 2009. The Randox Evidence MultiStat is a revolutionary benchtop analyser which offers up to 8 cardiac results within just 20 minutes. To find out more visit hall 3, booth A08.
28 Sep 2009: Randox have developed three biochip arrays for the detection of a variety of antimicrobial agents. These arrays enable simultaneous multi-analyte testing of up to 12 antimicrobials from a single sample. Antimicrobial Array I tests for sulphonamides, Array II for general antibiotics and Array III for nitrofurans, chloramphenicol and malachite green.
24 Apr 2009: The analysis of postmortem blood is one of the most challenging tasks in forensic toxicology, but Randox can help through the development of their innovative biochip array technology applied to multi-analyte screening. The Randox Drugs of Abuse (DoA) biochips permit the simultaneous analysis of up to 10 drug classes per array from a single blood sample.
